Effects of MIYA-BM for clinical symptoms and gut microbiome in patients with chronic constipation.

Effects of MIYA-BM for clinical symptoms and gut microbiome in patients with chronic constipation. - Effects of MIYA-BM for clinical symptoms and gut microbiome in patients with chronic constipation.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040872

Enrollment

Registered

2020-06-23

Start date

2020-06-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic constipation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1, Patients who visited our department, seeking for treatment of constipation. 2, The score of Constipation Scoring System (0: no symptoms - 30: worst symptoms) is 5 or over. 3, Patients who can promise that they do not start or increase the dosage of medication for chronic constipation while they take MIYA-BM for 28-35 days in this study.

Exclusion criteria

Exclusion criteria: 1, Patients who took MIYA-BM within one month before entering this study. 2, Pregnant or lactating woman.

Design outcomes

Primary

Measure	Time frame
Symptomatic improvement of chronic constipation evaluated with Constipation Scoring System	—

Secondary

Measure	Time frame
1,Improvement of constipation specific quality of life evaluated with Japanese version of Patient Assessment of Quality of Life questionnaire (JPAC-QOL) 2,The comparison of bowel movement 3,The comparison of stool consistency 4,The comparison of gut microbiome	—

Countries

Japan

Contacts

Public ContactYuko Homma

Jichi Medical University Division of Gastroenterological, General and Transplant Surgery, Department of Surgery

y.homma@jichi.ac.jp0285-58-7371

Outcome results